Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. WALD
stocks logo

WALD

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
67.80M
-3.42%
--
--
72.65M
+0.79%
--
--
68.95M
+5.36%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Waldencast plc (WALD) for FY2025, with the revenue forecasts being adjusted by -5.45% over the past three months. During the same period, the stock price has changed by 2.21%.
Revenue Estimates for FY2025
Revise Downward
down Image
-5.45%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+269.5%
In Past 3 Month
Stock Price
Go Up
up Image
+2.21%
In Past 3 Month
Wall Street analysts forecast WALD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WALD is 3.50 USD with a low forecast of 3.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast WALD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WALD is 3.50 USD with a low forecast of 3.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.850
sliders
Low
3.00
Averages
3.50
High
4.00
Current: 1.850
sliders
Low
3.00
Averages
3.50
High
4.00
Canaccord
Buy
downgrade
$5 -> $4
2025-11-25
Reason
Canaccord
Price Target
$5 -> $4
2025-11-25
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Waldencast to $4 from $5 and keeps a Buy rating on the shares. The firm noted they announced their previously delayed 2Q results and also provided 3Q sales performance. Sales in both quarters came in below our and management's initial expectations, primarily due to weakness from the Milk Makeup brand. Looking ahead, management now expects sales for FY25 to be broadly in-line with FY24's sales.
Telsey Advisory
Telsey Advisory
Outperform -> Market Perform
downgrade
$3
2025-11-25
Reason
Telsey Advisory
Telsey Advisory
Price Target
$3
2025-11-25
downgrade
Outperform -> Market Perform
Reason
As previously reported, Telsey Advisory downgraded Waldencast (WALD) to Market Perform from Outperform with an unchanged price target of $3 following "disappointing" Q2 results that fell short of expectations on both the top and bottom line and the company reduced its FY25 outlook "again." Milk, which had been Waldencast's faster growing brand, has been impacted by out-of-stocks and lapping significant product launches last year, which weighed on sales despite distribution gains this year from Ulta Beauty (ULTA) and Amazon Premium Beauty (AMZN), the analyst tells investors.
Telsey Advisory
Outperform -> Market Perform
downgrade
$3
2025-11-25
Reason
Telsey Advisory
Price Target
$3
2025-11-25
downgrade
Outperform -> Market Perform
Reason
Telsey Advisory downgraded Waldencast to Market Perform from Outperform with an unchanged price target of $3.
TD Cowen
Jonna Kim
Hold
downgrade
$2
2025-08-20
Reason
TD Cowen
Jonna Kim
Price Target
$2
2025-08-20
downgrade
Hold
Reason
TD Cowen analyst Jonna Kim lowered the firm's price target on Waldencast to $2 from $2.40 and keeps a Hold rating on the shares. The firm noted the company launched an exploration of strategic alternatives and has postponed reporting 1H25. Key 2Q positives are sell-through momentum at Milk in the US and the core business at Obagi sequentially improving.
Telsey Advisory
Outperform
to
NULL
downgrade
$4 -> $3
2025-08-20
Reason
Telsey Advisory
Price Target
$4 -> $3
2025-08-20
downgrade
Outperform
to
NULL
Reason
Telsey Advisory lowered the firm's price target on Waldencast to $3 from $4 and keeps an Outperform rating on the shares. The moderated annual outlook comes as a disappointment as solid underlying trends are offset by softening international consumption, out of stocks at its brands, and exiting of non-core distribution points at Obagi, the analyst tells investors.
Canaccord
Buy
downgrade
$6 -> $5
2025-05-15
Reason
Canaccord
Price Target
$6 -> $5
2025-05-15
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Waldencast to $5 from $6 and keeps a Buy rating on the shares. The firm said Waldencast reported 1Q sales that were down citing supply chain and comp issues that hindered results. However, they did note brand demand saw an acceleration exiting the quarter.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Waldencast PLC (WALD.O) is -4.44, compared to its 5-year average forward P/E of 16.14. For a more detailed relative valuation and DCF analysis to assess Waldencast PLC 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
16.14
Current PE
-4.44
Overvalued PE
149.73
Undervalued PE
-117.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
14.08
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
18.75
Undervalued EV/EBITDA
9.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.09
Current PS
0.00
Overvalued PS
3.11
Undervalued PS
1.06
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

WALD News & Events

Events Timeline

(ET)
2025-12-04
16:40:00
Waldencast Files to Sell 9.82M Class A Ordinary Shares
select
2025-11-24 (ET)
2025-11-24
07:02:27
Waldencast Reports That Strategic Review is Still in Progress
select
2025-11-24
07:01:29
Waldencast anticipates FY25 net revenue to be "generally consistent" with 2024.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
12-11PRnewswire
Waldencast Under Investigation Amid $185.2M Loss in H1 2025
  • Investigation Launched: Pomerantz LLP is investigating whether Waldencast plc has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to stock price volatility.
  • Financial Outlook Downgraded: Waldencast has revised its 2025 financial outlook, expecting net revenue to align with 2024, while adjusted EBITDA margin is projected to be in the high single digits, significantly lower than the previously anticipated mid-to-high teens, indicating a notable decline in profitability.
  • Substantial Losses: The company reported a net loss of $185.2 million for the first half of 2025, primarily due to impairment charges of $132.1 million and $20 million on its Obagi Medical and Milk Makeup brands, raising concerns among investors regarding brand value.
  • Stock Price Reaction: Following the financial report on November 24, 2025, Waldencast's Class A ordinary share price fell by $0.20, or 6.49%, closing at $2.88 per share, reflecting the market's negative reaction to the company's financial health.
[object Object]
Preview
4.0
11-29Yahoo Finance
Recent Developments Influencing the Waldencast Investment Narrative

  • Analyst Price Target Adjustment: Waldencast's consensus analyst price target has been lowered from $3.50 to $3.20, indicating a less optimistic outlook on the company's fair value and future revenue growth.

  • Bullish and Bearish Perspectives: Analysts noted distribution gains for Waldencast's core brands, particularly through major retailers, while also expressing concerns over disappointing Q2 results and sales softness for the Milk brand due to stock issues.

  • Financial Performance and Outlook: Waldencast reported a significant loss on impairment of goodwill and revised its 2025 earnings outlook, expecting net revenue to remain stable as consumer demand softens for Milk Makeup.

  • Regulatory Developments: The U.S. FDA approved Obagi saypha MagIQ injectable gel, marking Waldencast's entry into the HA dermal filler market, with a commercial launch anticipated in 2026.

[object Object]
Preview
4.0
11-26Benzinga
Canaccord Genuity Keeps Buy Rating on Waldencast, Reduces Price Target to $4

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, sharing strategies and information.

  • Market Winning Tools: Benzinga Pro is designed to help traders win in the markets every day with accurate stock market intelligence.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Waldencast PLC (WALD) stock price today?

The current price of WALD is 1.85 USD — it has decreased -4.64 % in the last trading day.

arrow icon

What is Waldencast PLC (WALD)'s business?

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.

arrow icon

What is the price predicton of WALD Stock?

Wall Street analysts forecast WALD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WALD is 3.50 USD with a low forecast of 3.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Waldencast PLC (WALD)'s revenue for the last quarter?

Waldencast PLC revenue for the last quarter amounts to 65.44M USD, decreased % YoY.

arrow icon

What is Waldencast PLC (WALD)'s earnings per share (EPS) for the last quarter?

Waldencast PLC. EPS for the last quarter amounts to USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Waldencast PLC (WALD)'s fundamentals?

The market is revising Downward the revenue expectations for Waldencast plc (WALD) for FY2025, with the revenue forecasts being adjusted by -5.45% over the past three months. During the same period, the stock price has changed by 2.21%.
arrow icon

How many employees does Waldencast PLC (WALD). have?

Waldencast PLC (WALD) has 332 emplpoyees as of December 13 2025.

arrow icon

What is Waldencast PLC (WALD) market cap?

Today WALD has the market capitalization of 235.45M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free